Literature DB >> 30873603

'Just 17 if you know what I mean' … but what do we really mean to say about Th17 immunity?

Daniel M Altmann1.   

Abstract

Th17-derived IL-17 might be considered the archetypal pro-inflammatory cytokine of adaptive immunity, to be targeted by new therapeutics for alleviation of autoimmune and inflammatory disease. However, the IL-17 family of cytokines is produced by diverse innate and adaptive cells, including Th17, Tc17, ILC3, NK cells and γδ T-cells. These responses are appreciated to underpin diverse aspects of protective, physiological immunity, from dialogue with the gut microbiota to bacterial and fungal immunity in the lung.
© 2019 John Wiley & Sons Ltd.

Entities:  

Mesh:

Year:  2019        PMID: 30873603      PMCID: PMC6418453          DOI: 10.1111/imm.13055

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  10 in total

Review 1.  Therapeutic Targeting of IL-17 and IL-23 Cytokines in Immune-Mediated Diseases.

Authors:  George E Fragoulis; Stefan Siebert; Iain B McInnes
Journal:  Annu Rev Med       Date:  2015-11-04       Impact factor: 13.739

Review 2.  The aryl hydrocarbon receptor: an environmental sensor integrating immune responses in health and disease.

Authors:  Veit Rothhammer; Francisco J Quintana
Journal:  Nat Rev Immunol       Date:  2019-03       Impact factor: 53.106

Review 3.  Updates on T helper type 17 immunity in respiratory disease.

Authors:  Naoki Iwanaga; Jay K Kolls
Journal:  Immunology       Date:  2018-10-24       Impact factor: 7.397

4.  Interleukin-17/interleukin-17 receptor axis elicits intestinal neutrophil migration, restrains gut dysbiosis and lipopolysaccharide translocation in high-fat diet-induced metabolic syndrome model.

Authors:  Malena M Pérez; Larissa M S Martins; Murilo S Dias; Camila A Pereira; Jefferson A Leite; Enrico C S Gonçalves; Paula Z de Almeida; Emanuelle N de Freitas; Rita C Tostes; Simone G Ramos; Marcel R de Zoete; Bernhard Ryffel; João S Silva; Daniela Carlos
Journal:  Immunology       Date:  2018-12-27       Impact factor: 7.397

5.  Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain.

Authors:  Daniel J Cua; Jonathan Sherlock; Yi Chen; Craig A Murphy; Barbara Joyce; Brian Seymour; Linda Lucian; Wayne To; Sylvia Kwan; Tatyana Churakova; Sandra Zurawski; Maria Wiekowski; Sergio A Lira; Daniel Gorman; Robert A Kastelein; Jonathon D Sedgwick
Journal:  Nature       Date:  2003-02-13       Impact factor: 49.962

6.  Induction of intestinal Th17 cells by segmented filamentous bacteria.

Authors:  Ivaylo I Ivanov; Koji Atarashi; Nicolas Manel; Eoin L Brodie; Tatsuichiro Shima; Ulas Karaoz; Dongguang Wei; Katherine C Goldfarb; Clark A Santee; Susan V Lynch; Takeshi Tanoue; Akemi Imaoka; Kikuji Itoh; Kiyoshi Takeda; Yoshinori Umesaki; Kenya Honda; Dan R Littman
Journal:  Cell       Date:  2009-10-30       Impact factor: 41.582

7.  The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins.

Authors:  Marc Veldhoen; Keiji Hirota; Astrid M Westendorf; Jan Buer; Laure Dumoutier; Jean-Christophe Renauld; Brigitta Stockinger
Journal:  Nature       Date:  2008-03-23       Impact factor: 49.962

Review 8.  Segmented filamentous bacteria-induced immune responses: a balancing act between host protection and autoimmunity.

Authors:  Kyle L Flannigan; Timothy L Denning
Journal:  Immunology       Date:  2018-05-17       Impact factor: 7.397

Review 9.  Interleukin-17-producing γδ T (γδ17) cells in inflammatory diseases.

Authors:  Aoi Akitsu; Yoichiro Iwakura
Journal:  Immunology       Date:  2018-09-10       Impact factor: 7.397

10.  Preferential recruitment of CCR6-expressing Th17 cells to inflamed joints via CCL20 in rheumatoid arthritis and its animal model.

Authors:  Keiji Hirota; Hiroyuki Yoshitomi; Motomu Hashimoto; Shinji Maeda; Shin Teradaira; Naoshi Sugimoto; Tomoyuki Yamaguchi; Takashi Nomura; Hiromu Ito; Takashi Nakamura; Noriko Sakaguchi; Shimon Sakaguchi
Journal:  J Exp Med       Date:  2007-11-19       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.